Macquarie Reiterates Outperform Rating on Takeda Pharmaceutical (4502:JP) (TAK)

March 31, 2026 3:19 AM

Macquarie analyst Tony Ren ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found